ipos

CI Global's Geof Marshall explains where its private markets funds are making moves, why it's avoided software and likes legal services.

The breadth of growth opportunities on the ASX has been steadily declining, but a few under-the-radar names still stand out.

A deep dive into one of Australia's fastest growing fast food chains

I recently wrote about the then-upcoming Guzman y Gomez (ASX:GYG) float. That post and its associated social media mentions engendered some polarized views. Curiously,...

Ahead of Guzman Y Gomez's (ASX: GYG) IPO - and rumours of Canva, three founders discuss the measures of success.

LTR Pharma is a clinical-stage pharmaceutical company, commercialising a world first in erectile dysfunction, Spontan, a PDE5 nasal spray.

And what this means for private equity exits and returns in the future.

Successful investing in small caps is as much about what you don’t invest in, as what you do. Stephen Wood has built his successful track record on taking a prudent...

Stocks fell Monday, extending January's losses as investors pared back over-optimistic bets on when the first interest rate cut might occur.

Macquarie has reviewed the Sigma-CWG merger against the recent jump in Sigma Healthcare shares, forming a dim view of the stock's valuation.